Rezultaty - Michael Polydefkis
- Rezultaty 1 - 20 Rezultaty od 51
- Idź do następnej strony
-
1
-
2
-
3
-
4
Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression od David Adams, Vincent Algalarrondo, Michael Polydefkis, Nitasha Sarswat, Michel Slama, José Nativi-Nicolau
Wydane 2021Artigo -
5
-
6
-
7
-
8
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy od Michael Polydefkis, Peter Hauer, Soham Sheth, Michael Sirdofsky, John W. Griffin, Justin C. McArthur
Wydane 2004Artigo -
9
-
10
-
11
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the <scp>United States</scp>: <scp>Recommendations</scp> from a panel of experts od Chafic Karam, Michelle L. Mauermann, Alejandra González‐Duarte, Michelle Kaku, Senda Ajroud‐Driss, Thomas H. Brannagan, Michael Polydefkis
Wydane 2024Artigo -
12
-
13
Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-l... od Simina Ticau, Emre Aldinc, Michael Polydefkis, David Adams, Teresa Coelho, Mitsuharu Ueda, Cecilia Hale, Joshua R. Vest, Paul Nioi
Wydane 2023Artigo -
14
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7 od P. James B. Dyck, Alejandra González‐Duarte, Laura Obici, Michael Polydefkis, Janice F. Wiesman, Ilia Antonino, William J. Litchy, P. James B. Dyck
Wydane 2019Revisão -
15
-
16
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection od Malcolm S. Duthie, Maria T. Peña, Gigi J. Ebenezer, Thomas P. Gillis, Rahul Sharma, Kelly Cunningham, Michael Polydefkis, Yumi Maeda, Masahiko Makino, Richard W. Truman, Steven G. Reed
Wydane 2018Artigo -
17
-
18
Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B study od Thibaud Damy, Zubair Shah, Brian Drachman, Pedro Vellosa Schwartzmann, Cláudio Tinoco Mesquita, Michael Polydefkis, Laura Obici, Patrick Y. Jay, Shaun Bender, Kelley E. Capocelli, Mazen Hanna
Wydane 2023Artigo -
19
Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis od Bairavi Shankar, Lisa R. Yanek, Artrish Jefferson, Vivek Jani, Emily Brown, Daniel Tsottles, Jennifer Barranco, Serena Zampino, Mark J. Ranek, Kavita Sharma, Michael Polydefkis, Joban Vaishnav
Wydane 2024Artigo -
20
Comparison of efficacy outcomes with Vutrisiran vs. Patisiran in hATTR amyloidosis with polyneuropathy: post-hoc analysis of the HELIOS-A study od Michael Polydefkis, Frank Birklein, Yoshiki Sekijima, Davide Pareyson, Márcia Waddington‐Cruz, Raphael Santa Rosa Sayegh, David Danese, Kelley E. Capocelli, Madeline Merkel, Chongshu Chen, Joshua R. Vest, David Adams
Wydane 2023Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Amyloidosis
Transthyretin
Polyneuropathy
Pathology
Endocrinology
Biology
Gastroenterology
Surgery
Diabetes mellitus
Disease
Nursing
Physical therapy
Quality of life (healthcare)
Alternative medicine
Anatomy
Neuroscience
Peripheral neuropathy
Placebo
Anesthesia
Clinical trial
Gene
Genetics
Oncology
Psychiatry
Biochemistry
Biopsy
Confidence interval
Environmental health